Published in N Engl J Med on September 17, 1992
Apolipoprotein L1 gene variants in deceased organ donors are associated with renal allograft failure. Am J Transplant (2015) 2.62
Long-term kidney isografts develop functional and morphologic changes that mimic those of chronic allograft rejection. Ann Surg (1994) 0.93
HLA and cross-reactive antigen group matching for cadaver kidney allocation. Transplantation (1997) 0.89
HLA matching and the point system. Clin Transplant (1993) 0.80
Zebularine induces long-term survival of pancreatic islet allotransplants in streptozotocin treated diabetic rats. PLoS One (2013) 0.77
A Comparative Effectiveness Analysis of Early Steroid Withdrawal in Black Kidney Transplant Recipients. Clin J Am Soc Nephrol (2016) 0.77
Kidney graft loss in children: implications for program development. CMAJ (1998) 0.75
Aspects of liver transplant pathology with emphasis on rejection and its mechanisms. J Clin Pathol (1994) 0.75
Survival of nationally shared, HLA-matched kidney transplants. N Engl J Med (1993) 0.75
Every kidney counts. N Engl J Med (1992) 0.75
The role of HLA typing in clinical kidney transplants: 30 years later. The blind-folding of HLA matching. Clin Transpl (1993) 0.75
The Privilege of Induction Avoidance and Calcineurin Inhibitors Withdrawal in 2 Haplotype HLA Matched White Kidney Transplantation. Transplant Direct (2017) 0.75
Nephrology, dialysis and transplantation. Postgrad Med J (1993) 0.75
[Assessment of the need for organ transplantation in Quebec]. CMAJ (1994) 0.75
Impact of Cardiovascular Risk Factors on Graft Outcome Disparities in Black Kidney Transplant Recipients. Hypertension (2016) 0.75
High association of an HL-A antigen, W27, with ankylosing spondylitis. N Engl J Med (1973) 9.90
Serotyping for homotransplantation. 18. Refinement of microdroplet lymphocyte cytotoxicity test. Transplantation (1968) 8.51
The use of cyclosporin A and prednisone in cadaver kidney transplantation. Surg Gynecol Obstet (1980) 7.40
Microdroplet testing for HLA-A, -B, -C, and -D antigens. The Phillip Levine Award Lecture. Am J Clin Pathol (1978) 6.88
Significance of the positive crossmatch test in kidney transplantation. N Engl J Med (1969) 5.50
High survival rates of kidney transplants from spousal and living unrelated donors. N Engl J Med (1995) 5.41
Autologous stimulation of human lymphocyte subpopulation. J Exp Med (1975) 4.80
Cytotoxins in disease. Autocytotoxins in lupus. N Engl J Med (1970) 4.40
Serotyping for homotransplantation. X. Survival of 196 grafted kidneys subsequent to typing. Transplantation (1967) 4.16
Shwartzman reaction after human renal homotransplantation. N Engl J Med (1968) 4.05
Kidney preservation for transportation. Initial perfusion and 30 hours' ice storage. Lancet (1969) 3.67
Effect of blood transfusions on subsequent kidney transplants. Transplant Proc (1973) 3.42
Chimerism after liver transplantation for type IV glycogen storage disease and type 1 Gaucher's disease. N Engl J Med (1993) 3.36
Nomenclature for factors of the HLA system, 2010. Tissue Antigens (2010) 3.22
Effect of pravastatin on outcomes after cardiac transplantation. N Engl J Med (1995) 3.11
Chronic survival after human renal homotransplantation. Lymphocyte-antigen matching, pathology and influence of thymectomy. Ann Surg (1965) 3.00
Improvement of kidney-graft survival with increased numbers of blood transfusions. N Engl J Med (1978) 2.52
Transplantation of kidneys from donors whose hearts have stopped beating. N Engl J Med (1998) 2.48
Association of primary sclerosing cholangitis with HLA-DRw52a. N Engl J Med (1990) 2.40
Thoracic duct drainage before and after cadaveric kidney transplantation. Surg Gynecol Obstet (1979) 2.33
Heterologous antilymphocyte glubulin, histoincompatiblity matching, and human renal homotransplantation. Surg Gynecol Obstet (1968) 2.23
The relative effects of FK506 and cyclosporine on short- and long-term kidney graft survival. Transplantation (1995) 2.13
Oral delivery of insulin. Lancet (1990) 2.13
Equitable allocation of HLA-compatible kidneys for local pools and minorities. N Engl J Med (1994) 2.12
Reactivity of lymphocytes from normal persons on cultured tumor cells. Cancer Res (1973) 2.11
Human renal transplants. I. Glomerular changes. Lab Invest (1967) 2.06
Characterization of sialosylated Lewisx as a new tumor-associated antigen. Cancer Res (1984) 2.02
Nomenclature for factors of the HLA system, 2002. Tissue Antigens (2002) 1.89
Analysis of HL-A incompatibility in human renal transplants. Tissue Antigens (1971) 1.89
A semimicro mixed leukocyte culture test. Transplantation (1971) 1.85
Juvenile myoclonic epilepsy (JME) may be linked to the BF and HLA loci on human chromosome 6. Am J Med Genet (1988) 1.82
Serotyping for homotransplantation. V. Evaluation of a matching scheme. Transplantation (1966) 1.78
Deleterious effects of delayed graft function in cadaveric renal transplant recipients independent of acute rejection. Transplantation (1998) 1.78
Enhancement of human kidney allografts by cold B-lymphocyte cytotoxins. Lancet (1978) 1.70
Spinocerebellar ataxia and HLA linkage: risk prediction by HLA typing. N Engl J Med (1977) 1.67
Multiple sclerosis: association with HL-A3. Tissue Antigens (1972) 1.65
Inflammation in areas of tubular atrophy in kidney allograft biopsies: a potent predictor of allograft failure. Am J Transplant (2010) 1.65
Successful renal allografts across a positive cross-match for donor B-lymphocyte alloantigens. Lancet (1976) 1.63
The hyperfiltration hypothesis in human renal transplantation. Transplantation (1994) 1.63
Disturbance of HL-A antigen frequency in Psoriasis. N Engl J Med (1972) 1.63
Living unrelated donor kidney transplantation. Kidney Int (2000) 1.61
Thoracic duct fistula and renal transplantation. Ann Surg (1979) 1.60
Cross reactions between human transplantation antigens and bacterial lipopolysaccharides. Transplantation (1973) 1.60
Influence of race on kidney transplant survival. Transplant Proc (1977) 1.58
Treatment of lymphopenic hypogammaglobulinemia and bone-marrow aplasia by transplantation of allogeneic marrow. Crucial role of histocompatiility matching. N Engl J Med (1969) 1.58
Increased prevalence of W27 in juvenile rheumatoid arthritis. N Engl J Med (1974) 1.58
Selecting donors of platelets for refractory patients on the basis of HLA antibody specificity. Transfusion (2000) 1.58
Nomenclature for factors of the HLA system, 2004. Tissue Antigens (2005) 1.57
Structure of murine Ia antigens: partial NH2-terminal amino acid sequences of products of the I-E or I-C subregion. Proc Natl Acad Sci U S A (1977) 1.56
HLA matching and cadaver kidney transplant survival in North America: influence of center variation and presensitization. Transplantation (1977) 1.56
Empirical validation of the Essen-Möller probability of paternity. Am J Hum Genet (1986) 1.56
Follow-up study of juvenile chronic polyarthritis with particular reference to histocompatibility antigen W. 27. Ann Rheum Dis (1974) 1.55
Anti-HLA antibodies after solid organ transplantation. Transplantation (2000) 1.54
Expanding the donor kidney pool: utility of renal allografts procured in a setting of uncontrolled cardiac death. Am J Transplant (2006) 1.53
Impact of IgG3 subclass and C1q-fixing donor-specific HLA alloantibodies on rejection and survival in liver transplantation. Am J Transplant (2015) 1.50
HL-A antigens and antibody response after influenza A vaccination. Decreased response associated with HL-A type W16. N Engl J Med (1976) 1.49
HLA and the inheritance of multiple sclerosis: linkage analysis of 72 pedigrees. Am J Hum Genet (1980) 1.46
Cytotoxins in disease. 3. Antibodies against lymphocytes produced by vaccination. Transplantation (1970) 1.46
HLA genotypic study of insulin-dependent diabetes the excess of DR3/DR4 heterozygotes allows rejection of the recessive hypothesis. Diabetes (1983) 1.45
Higher risk of kidney graft failure in the presence of anti-angiotensin II type-1 receptor antibodies. Am J Transplant (2013) 1.44
Suppression of lymphocyte transformation by aspirin. Lancet (1973) 1.43
Twins with two different fathers identified by HLA. N Engl J Med (1978) 1.43
Extremely high association between appearance of HLA antibodies and failure of kidney grafts in a five-year longitudinal study. Am J Transplant (2007) 1.43
Paired kidney exchange is not a solution to ABO incompatibility. Transplantation (1998) 1.43
LIGHT AND ELECTRON MICROSCOPIC STUDY OF BIOPSIES FROM THIRTY-THREE HUMAN RENAL ALLOGRAFTS AND AN ISOGRAFT 134-212 YEARS AFTER TRANSPLANTATION. Ann N Y Acad Sci (1996) 1.42
HL-A W27--a clue to the diagnosis and pathogenesis of Reiter's syndrome. N Engl J Med (1974) 1.41
HLA matching assessed from early graft function. Transplant Proc (1987) 1.40
Poor kidney-transplant survival in recipients with frozen-blood transfusions or no transfusions. Lancet (1974) 1.40
Nomenclature for factors of the HLA system, 1998. Tissue Antigens (1999) 1.40
Genetics of four new HL-A specificities in the Caucasian and Negro populations. Transplant Proc (1971) 1.38
Serotyping for homotransplantation. XIX. Experience with an interhospital scheme of cadaver-kidney sharing and tissue typing. JAMA (1969) 1.38
Analyses of the UNOS Scientific Renal Transplant Registry at three years--early events affecting transplant success. Transplantation (1992) 1.37
HLA-B14 antigen and postencephalitic Parkinson's disease. Their association in an American-Jewish ethnic group. Arch Neurol (1980) 1.37
Suppression of post-hypoxic and post-encephalitic myoclonus with levetiracetam. Neurology (2001) 1.36
Group-specific human granulocyte antigens on a chronic myelogenous leukemia cell line with a Philadelphia chromosome marker. Blood (1977) 1.35
Flow cytometric detection of HLA antibodies using a spectrum of microbeads. Hum Immunol (1999) 1.34
Cross-reactions between streptococcal M proteins and human transplantation antigens. Science (1970) 1.33
Prospective registry-based observational cohort study of the long-term risk of malignancies in renal transplant patients treated with mycophenolate mofetil. Am J Transplant (2005) 1.33
Presensitization and kidney transplant failures. Postgrad Med J (1971) 1.33
Serotyping for homotransplantation. IX. Evaluation of leukocyte antigen matching with the clinical course and rejection types. Transplantation (1967) 1.32
A new microcellular cytotoxicity test based on calcein AM release. Hum Immunol (1993) 1.32
Sjögren's syndrome association with HLA-Dw3. N Engl J Med (1977) 1.32
Serotyping for homotransplantation. XVI. Analysis of kidney transplants from unrelated donors. N Engl J Med (1968) 1.31
Close genetic linkage between diabetes mellitus and kidd blood group. Lancet (1981) 1.30
High mean fluorescence intensity donor-specific anti-HLA antibodies associated with chronic rejection Postliver transplant. Am J Transplant (2011) 1.29
Maternal-fetal incompatibility. I. Incidence of HL-A antibodies and possible association with congenital anomalies. Transplantation (1970) 1.28